Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alternativeName |
RWJ-64809
RWJ64809 |
| gptkbp:CASNumber |
gptkb:170729-80-3
|
| gptkbp:chemicalFormula |
C23H27N3O2
|
| gptkbp:developedBy |
gptkb:Johnson_&_Johnson
|
| gptkbp:drugClass |
gptkb:serotonin_receptor_antagonist
5-HT1B receptor antagonist 5-HT1D receptor antagonist |
| gptkbp:IUPACName |
N-[4-(4-methoxyphenyl)piperazin-1-yl]-2-phenylacetamide
|
| gptkbp:molecularWeight |
377.48 g/mol
|
| gptkbp:PubChem_CID |
9942227
CHEMBL2105702 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
gptkb:investigational_drug
|
| gptkbp:studiedBy |
gptkb:depression
anxiety migraine |
| gptkbp:bfsParent |
gptkb:SB203580
|
| gptkbp:bfsLayer |
7
|
| http://www.w3.org/2000/01/rdf-schema#label |
RWJ 64809
|